Affymetrix Enters Settlement Agreement with Shareholders over Derivative Suit | GenomeWeb

NEW YORK (GenomeWeb News) – Affymetrix disclosed in a filing with the US Securities and Exchange Commission today that it has entered into a settlement agreement regarding litigation with shareholders who had sued certain executives of the company for allegedly back-dating stock options and pocketing "hundreds of millions of dollars of corporate assets."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.